Page last updated: 2024-10-16

beta-alanine and Arteriosclerosis, Coronary

beta-alanine has been researched along with Arteriosclerosis, Coronary in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Dabigatran is a direct thrombin inhibitor and its role in patients with acute coronary syndrome is being explored."6.49Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran. ( Doraiswamy, VA; Gesheff, MG; Gurbel, PA; Slepian, MJ; Tantry, US, 2013)
"Dabigatran is a direct thrombin inhibitor and its role in patients with acute coronary syndrome is being explored."2.49Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran. ( Doraiswamy, VA; Gesheff, MG; Gurbel, PA; Slepian, MJ; Tantry, US, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doraiswamy, VA1
Slepian, MJ1
Gesheff, MG1
Tantry, US1
Gurbel, PA1
Shavadia, J1
Welsh, RC1

Reviews

1 review available for beta-alanine and Arteriosclerosis, Coronary

ArticleYear
Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran.
    Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:9

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Coronary Artery Disease; Dabigatran; Drug Therapy, Com

2013

Other Studies

1 other study available for beta-alanine and Arteriosclerosis, Coronary

ArticleYear
Acute management of ST-elevation myocardial infarction patients taking dabigatran.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:11

    Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Coronary Artery Disease; Dabigatran; Drug-Eluting

2013